Compare Novartis AG (NVS) vs Teradyne, Inc. (TER) Price & Performance

Novartis AGTrade

Teradyne, Inc.Trade

Price performance (Past 24H)

Key statistics

Novartis AG vs Teradyne, Inc. — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Teradyne, Inc. trades at $373.29 (market cap $52.25B). The key difference: Novartis AG is far larger — about 5.6× Teradyne, Inc.'s market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.

	NVS	TER
Market Cap	$290.25B	$52.25B
Sector	Health	Technology
52-Week High	$168.62	$483.84
52-Week Low	$113.50	$90.15
Enterprise Value	$330.27B	$52.08B
Dividend Yield	3.17%	0.16%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 22 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 4 days agoBullish View details →

TER

Teradyne stock rises on strong AI-driven semiconductor testing demand, targeting $407 price.Seeking Alpha · 3 days agoBullish View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

About Teradyne, Inc.

Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.